Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Tadatsugu Sato"'
Autor:
Makoto Okuda, Yutaka Nagura, Koji Kishino, Naohito Itami, Kenichi Kushibiki, Hiroko Kuribayashi, Mina Komoto, Kohei Saito, Tatsuya Sugimoto, Junichi Terauchi, Akito Nozaki, Shinji Yoshii, Ayako Endo, Tadatsugu Sato, Eizaburo Sueoka, Masayuki Suzuki, Koki Takahashi, Yoko Hidaka, Motohiro Fujii, Kaoru Yashiro
Publikováno v:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi; 2024, Vol. 70 Issue 1, p7-11, 5p
Autor:
Tadatsugu Sato
Publikováno v:
Japanese Journal of Clinical Immunology. 24:65-74
Publikováno v:
Blood. 90:4749-4758
Interferon-gamma (IFN-gamma) is a potent inhibitor of hematopoiesis in vitro and has been implicated in the pathophysiology of human bone marrow failure syndromes. IFN-gamma both inhibits cell cycling and induces expression of the Fas-receptor, resul
Autor:
Elaine M. Sloand, Jaroslaw P. Maciejewski, Frank F. Weichold, Neal S. Young, Tadatsugu Sato, Sonnie Kim, Princy Kumar
Publikováno v:
AIDS. 11:1547-1553
OBJECTIVE: To determine if defective bone marrow function in HIV infection is associated with decreased numbers of progenitor cells or defective stromal cell function. DESIGN: Defective bone marrow function may in part be responsible for the cytopeni
Publikováno v:
Blood. 89:1173-1181
Paroxysmal nocturnal hemoglobinuria (PNH) results from somatic mutations in the PIG-A gene, leading to poor presentation of glycosylphosphatidylinositol (GPI)-anchored surface proteins. PNH frequently occurs in association with suppressed hematopoies
Publikováno v:
Blood. 89:1357-1363
Direct killing of CD4+ lymphocytes by human immunodeficiency virus-1 (HIV-1) probably cannot account for the magnitude of the loss of these cells during the course of HIV-1 infection. Experimental evidence supports a pathophysiologic role of the apop
Autor:
Luigi Del Vecchio, Neal S. Young, Jaroslaw P. Maciejewski, Tadatsugu Sato, Bruno Rotoli, A. John Barrett, Luigia Luciano, Carmine Selleri
Publikováno v:
Blood. 89:957-964
Interferon-α (IFN-α) is an established treatment for chronic myelogenous leukemia (CML) in chronic phase, but the mechanism of its antileukemic activity is not clear. One possible mechanism of action might include the induction of apoptosis, and es
Publikováno v:
Blood. 88:1983-1991
We examined the stem cell compartment of patients with acquired aplastic anemia (AA) using the long-term culture-initiating cell assay (LTC-IC), in parallel with measurements of CD34+ cells and mature hematopoietic progenitors. Secondary colonies fro
Publikováno v:
Blood. 87:4149-4157
Clinical and laboratory studies have suggested involvement of interferon-gamma (IFN-gamma) in the pathophysiology of aplastic anemia. T cells from aplastic anemia (AA) patients secrete IFN-gamma in vitro, activated cytotoxic lymphocytes infiltrate ap
Publikováno v:
Journal of Cellular Physiology. 165:538-546
Increased expression of interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) in bone marrow failure disorders suggests a possible pathophysiologic role of these cytokines in disease. In this study, we tested the action of TNF-alph